Donor characteristics and hematopoietic stem cell transplantation outcome: experience of a single center in Southern Brazil
AUTOR(ES)
Paz, Alessandra, Rigoni, Lisandra, Fischer, Gustavo, Schittler, Monise, Pezzi, Annelise, Valim, Vanessa, Dahmer, Alice, Zambonato, Bruna, Amorin, Bruna, Sehn, Filipe, Silva, Maria Aparecida da, Daudt, Liane, Silla, Lucia
FONTE
Hematol., Transfus. Cell Ther.
DATA DE PUBLICAÇÃO
2018-06
RESUMO
ABSTRACT Background: Hematopoietic stem cell transplantation is a curative treatment for many patients with hematological disorders. Donor–recipient genetic disparity, especially involving the human leukocyte antigen system is a critical factor for transplant outcome. Objective: To evaluate retrospectively donor characteristics and correlations with the occurrence of acute and chronic graft-versus-host disease, disease-free survival and overall survival in a Brazilian population submitted to allogeneic hematopoietic stem cell transplantation between 1994 and 2012 in a single center. Results: Three hundred and forty-seven consecutive transplantations were included. Related transplants (81.2%) were significantly more common than unrelated transplants (18.7%); donor and recipient median ages were 34 (range: 1–61) and 33 (range: 3–65) years respectively with donor HLAs being matched for 333 (95.9%) patients. Donor gender, cytomegalovirus status and ABO incompatibility did not influence the five-year overall survival. In univariate analyses, overall survival was negatively influenced by the presence of acute graft-versus-host disease (33% vs. 47%, respectively; p-value = 0.04), unrelated transplant (41.5% vs. 50.9%, respectively; p-value = 0.045) and donors aged over 40 years (41% vs. 52%, respectively; p-value = 0.03). Older donors were associated with a higher rate of acute (52% vs. 65.8%; p-value = 0.03) and chronic graft-versus-host disease (60% vs. 43%, respectively; p-value = 0.015). In multivariate analyses, acute graft-versus-host disease [relative risk (RR): 1.8; 95% confidence interval (CI): 1.1–29; p-value = 0.008] and older donors (RR: 1.6; 95% CI 1.11–2.24; p-value = 0.013) were associated with higher transplant-related mortality. Conclusions: In transplant patients, to have a donor older than 40 years of age seems to significantly increase the incidence of acute and chronic graft-versus-host disease and transplant-related mortality with no impact on disease-free survival and overall survival. In spite of the rather small cohort of patients, these findings are similar to what is described in the literature suggesting that a younger donor should be chosen whenever possible.
Documentos Relacionados
- Unrelated hematopoietic stem cell transplantation in the pediatric population: single institution experience
- Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experience
- Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience
- Cytomegalovirus disease in patients with hematopoietic stem cell transplantation, experience over 8 years
- The need for endodontic treatment and systemic characteristics of hematopoietic stem cell transplantation patients